Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the vatiquinone mitochondrial-disease epilepsy study is displayed, with the study marked terminated and no longer recruiting. The record includes its study design and outcomes, posted results, eligibility details, and supporting documents.
    Difference
    83%
    Check dated 2026-11-10T19:08:21.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T19:31:15.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH transition notice appears above the ClinicalTrials.gov page, and the revision label changes from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T20:43:22.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision identifier is updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:17:39.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    - The study page now displays a 403 Forbidden error instead of the study details, blocking access to the trial information. This reflects a permissions issue on the page that prevents viewing the study record.
    Difference
    21%
    Check dated 2026-09-22T22:17:40.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Updated the study document revision from v3.6.6 to v3.7.0, signaling a newer version of the accompanying materials.
    Difference
    0.2%
    Check dated 2026-09-15T21:40:58.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.